Philip Morris battles to buy a medical inhale...

Up next

Martin Wolf on the US midterms: What’s the risk of political violence?

As Americans prepare to vote in the November 3 midterm elections, the FT’s chief economics commentator Martin Wolf asks what the result will mean for Donald Trump, the future of US democracy and America's place in the world. In the third of a six-part series, Martin speaks to pol ... Show more

. 36min 54sec

Alphabet’s brutal day on the stock market

Alphabet’s share price fell just over 12 percent on Thursday, and UK startup Nscale is banking on a troubled US data centre project to underpin its planned $35bn IPO. Plus, we look at what’s next for the ECB now that its president Christine Lagarde announced she’s stepping down.M ... Show more

. 12min 15sec

Recommended Episodes

Trump’s Tariffs: US vs China

Newscast

Today, we look at what seems like an escalation of a possible trade war between the US and China. Plus, the Prime Minister’s attempts to try and protect the UK car business. James and Chris are joined by business editor Simon Jack, on another very turbulent day in stock markets a ... Show more

. 32min 37sec

Tariff trade wars persist, Google’s antitrust allegations in China, Palantir soars

Morning Brief

Today on Morning Brief, anchors Brad Smith and Seana Smith tackle the biggest market stories and speak to top Wall Street experts ahead of the opening bell. Our hosts analyze some of the top trending tickers: Spotify (SPOT), PepsiCo (PEP), Merck (MRK) Takeaways: China retaliates ... Show more

. 52min 39sec

Bristol’s $14 Billion Karuna Deal Highlights Race for New Drugs

Bloomberg Businessweek

Laura Chico, Biotechnology Research Analyst at Wedbush Securities and Bloomberg News US Deals Team Leader Matthew Monks share their thoughts on the Bristol Myers acquisition Karuna Therapeutics. John Mowrey, CIO at NFJ Investment Group, explains where to find value in the markets ... Show more

. 1h 2min